Orifarm Generics A/S is a Danish A/S based in Odense S, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2000, the company has 250 employees and reported revenue of 2,5 mia. kr. in its latest annual filing.
In its most recent annual report (2025), Orifarm Generics A/S reported revenue of 2,5 mia. kr., an increase of 5% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of 77,2 mio. kr., and the EBITDA margin stood at 4.8%.
At the end of 2025, equity financed 39.4% of the balance sheet, and current assets covered short-term debt 1.6 times.
Frequently asked questions
What is the CVR number of Orifarm Generics A/S?
Orifarm Generics A/S is registered with CVR / Virk under CVR 25674030.
What is the revenue of Orifarm Generics A/S?
Orifarm Generics A/S reported revenue of 2,5 mia. kr. in 2025.
How many employees does Orifarm Generics A/S have?
Orifarm Generics A/S employs 250 people as of the latest annual report.
Who is the CEO of Orifarm Generics A/S?
Thomas Brandhof is the CEO of Orifarm Generics A/S, in role since 2025.
Who is the chairman of Orifarm Generics A/S?
Hans Carl Bøgh-Sørensen chairs the board of Orifarm Generics A/S, in role since 2011.
Where is Orifarm Generics A/S headquartered?
Orifarm Generics A/S's registered address is Energivej 15.
